Insiders / Novo Holdings A/S

Novo Holdings A/S

CIK 1388325institutionfundbeneficial ownerinsider
Companies
2
First seen
Jan 23, 2026
Last activity
May 15, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Hemab Therapeutics Holdings, Inc. · COAG10% owner4,180,5504,180,5505
Avalyn Pharma Inc. · AVLN10% owner3,883,2893,883,2897

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Avalyn Pharma Inc.Voting Common Stock3,883,289May 1, 2026
Hemab Therapeutics Holdings, Inc.Common Stock4,180,550May 4, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
May 1, 2026BuyAVLN
Avalyn Pharma Inc.
Voting Common Stock
$10.00M+556K
+16.69%
3,883,289
8.76% of shares
high
May 4, 2026OtherCOAG
Hemab Therapeutics Holdings, Inc.
Series C Preferred Stock
-33K
-100.00%
0
0.00% of shares
low
May 4, 2026OtherCOAG
Hemab Therapeutics Holdings, Inc.
Series B Preferred Stock
-62K
-100.00%
0
0.00% of shares
low
May 4, 2026OtherCOAG
Hemab Therapeutics Holdings, Inc.
Series A Preferred Stock
-72K
-100.00%
0
0.00% of shares
low
May 4, 2026OtherCOAG
Hemab Therapeutics Holdings, Inc.
Series Seed Preferred Stock
-23K
-100.00%
0
0.00% of shares
low
May 4, 2026OtherCOAG
Hemab Therapeutics Holdings, Inc.
Common Stock
+4.2M
4,180,550
8.95% of shares
low
May 1, 2026OtherAVLN
Avalyn Pharma Inc.
Series D Preferred Stock
-12.6M
-100.00%
0
0.00% of shares
low
May 1, 2026OtherAVLN
Avalyn Pharma Inc.
Series C-2 Preferred Stock
-5.6M
-100.00%
0
0.00% of shares
low
May 1, 2026OtherAVLN
Avalyn Pharma Inc.
Series C-1 Preferred Stock
-25.9M
-100.00%
0
0.00% of shares
low
May 1, 2026OtherAVLN
Avalyn Pharma Inc.
Series B Preferred Stock
-2.0M
-100.00%
0
0.00% of shares
low